BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$54.36 USD
-0.78 (-1.41%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $54.36 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
BioMarin Pharmaceutical Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BMRN 54.36 -0.78(-1.41%)
Will BMRN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BMRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BMRN
Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
BMRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Options Traders Betting on a Big Move in BioMarin Pharmaceutical Stock?
BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound?
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
Other News for BMRN
Is BMRN coiling for a breakout? NR7 shows up after rising 1.42%
November 21st Options Now Available For BioMarin Pharmaceutical (BMRN)
Is BMRN signaling a buying opportunity? Stochastic Buy Signal shows up after climbing 0.8%
Lower Bollinger Band Walk appears for BMRN after 1.51% move
Raymond James Sticks to Their Buy Rating for BioMarin Pharmaceutical (BMRN)